pros and cons of semaglutide and tirzepatide for weight loss vs. Loss: Which Is Right for Me? Tirzepatide vs. Semaglutide: Which is

Mounjaro may be the better choice if: You need treatment now (retatrutide is not yet available) You prefer a medication with extensive real-world safety data Your BMI qualifies you for current GLP-1 prescriptions You have type 2 diabetes (Mounjaro has robust diabetes data) You are sensitive to GI side effects and want a well-established titration protocol Your weight loss goals are achievable with 15 to 22% body weight reduction You want insurance coverage options (available for some plans) Mounjaro is the proven, accessible, right-now option

Sugary drinks such as soda, sweetened teas, and other sugar-sweetened beverages can make managing diabetes more difficult and impede weight loss

You must not have government insurance including Medicare Part D, Medicaid, Medigap, TRICARE, VA benefits, or any state pharmaceutical assistance program

Novo Nordisk the company behind Ozempic, Wegovy and Rybelsus reported $31.1 billion in revenue from the medications in 2024, up from $11.9 billion in 2022

3ag, j, k